UBE2NL
Putative ubiquitin-conjugating enzyme E2 N-like
Also known as: UE2NL_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q5JXB2
- Gene
- UBE2NL
- Canonical length
- 153 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for UBE2NL in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
153 residues, UniProt reviewed canonical sequence.
>Q5JXB2|UBE2NL
1 MAELPHRIIK ETQRLLAEPV PGIKAEPDES NARYFHVVIA GESKDSPFEG GTFKRELLLA
61 EEYPMAAPKV RFMTKIYHPN VDKLERISLD ILKDKWSPAL QIRTVLLSIQ ALLNAPNPDD
121 PLANDVVEQW KTNEAQAIET ARAWTRLYAM NSILocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBE2NL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 0.1 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- appendix: 0 nTPM
- bone marrow: 0 nTPM
- breast: 0 nTPM
Single-cell type
- megakaryocytes: 6.2 nCPM
- late spermatids: 3.1 nCPM
- early spermatids: 1 nCPM
- esophageal apical cells: 0.5 nCPM
- esophageal basal cells: 0.4 nCPM
- late primary spermatocytes: 0.4 nCPM
Immune cell
- memory B-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- T-reg: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- basal ganglia: 0.4 nTPM
- cerebral cortex: 0.3 nTPM
- hypothalamus: 0.3 nTPM
- midbrain: 0.3 nTPM
- thalamus: 0.3 nTPM
- amygdala: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.93
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.19
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBE2NL as an antibody target. Whether an autoantibody or antibody against UBE2NL could matter depends on whether native UBE2NL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBE2NL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBE2NL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...